← All stories
Markets
Why Is Clinical Cannabis Back in the Frame for MGC Pharmaceuticals (AIM:MXC) Today?
Highlights MGC Pharmaceuticals has acknowledged it is at a critical financial juncture as fundraising efforts have proven difficult The company's pipeline spans cannabinoid-derived medicines aimed at unmet clinical needs alongside consultin…
Covered by 1 outlet
All coverage · 1 article